Studies have found that vascular risk factors are associated with greater amyloid-β (Aβ) and tau burden, which are hallmark neuropathologies of Alzheimer's disease (AD). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.